Displaying results 85 - 96 of 115
Metabolism, Alcohol & Toxicity

Diabetes

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel discussion

Webcasts
View
Metabolism, Alcohol & Toxicity

Sodium-glucose cotransporter 2 inhibitor versus sulfonylurea in patients with type 2 diabetes and nonalcoholic fatty liver dis...

Webcasts
View
Metabolism, Alcohol & Toxicity

Oral poster blast (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

The patient’s perspective

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel discussion

Webcasts
View
Metabolism, Alcohol & Toxicity

The journey so far and next steps

Webcasts
View
Metabolism, Alcohol & Toxicity

Phase 1-2 drug candidates for non-cirrhotic NASH

Webcasts
View
Metabolism, Alcohol & Toxicity

Clinical trial landscape in 2022 (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Phase 3 non-cirrhotic NASH

Webcasts
View
Metabolism, Alcohol & Toxicity

Cirrhotic NASH

Webcasts
View
Metabolism, Alcohol & Toxicity

The journey towards a new nomenclature (Complete Session)

Webcasts
View
Displaying results 85 - 96 of 115